About MosebackeProvins

This author has not yet filled in any details.
So far MosebackeProvins has created 294 blog entries.

Restart for Tullinge work hub

Just before the pandemic, a research project was initiated in Tullinge in which residents were offered a place at a local work hub as an alternative to commuting to work. The hub is now seeing something of a reopening in a project aimed at increasing shared use and resource efficiency.

Restart for Tullinge work hub2022-06-23T08:51:33+02:00

Successful Kodkupan Flemingsberg pilot

During the Kodkupan award evening in Flemingsberg, parents got to see the results of middle school students’ programming projects. Games and animations from the project were shown, prompting laughter and applause.

Successful Kodkupan Flemingsberg pilot2022-06-23T09:34:33+02:00

Martin Jönsson: “The time is ripe for a breakthrough in dementia treatment”

Nearly 100,000 people in Sweden suffer from Alzheimer’s. Globally, about 30 million people are thought to have the disease. There is still no cure, but research is approaching a point where new drugs may become crucial. AlzeCure is one of the pharmaceutical companies that has made the most progress.

Martin Jönsson: “The time is ripe for a breakthrough in dementia treatment”2022-05-20T09:14:26+02:00

Cellaviva: improving lives through stem cell technology

“Cellaviva was founded by researchers from Karolinska Institutet, in the belief that stem cells will revolutionize how complex and incurable diseases are treated. We are a biobank that helps expectant parents to save stem cells from the umbilical cord at birth, in a so-called family bank. The aim is to make high-quality, potent cells available quickly, if medical needs arise. This creates treatment opportunities and expands therapy options for the whole family,”

Cellaviva: improving lives through stem cell technology2022-05-17T11:03:00+02:00

NextCell to treat type 1 diabetes in children with stem cells

NextCell Pharma in Flemingsberg has published extremely promising results from its clinical studies of drug candidate ProTrans for the treatment of type 1 diabetes. A study is now being carried out with the aim of examining its efficacy in children and young people.

NextCell to treat type 1 diabetes in children with stem cells2022-05-17T10:39:49+02:00

Flemingsberg middle school students learn all about coding

The “Kodkuporna” programme started in Flemingsberg in May, a project that gives children and young people the opportunity to try their hand at programming. Students from KTH and Södertörn University mentor middle school students from Vistaskolan in play-based learning.

Flemingsberg middle school students learn all about coding2022-05-17T10:10:50+02:00

“We want to increase the interest from the industry to collaborate with researchers”

The pre-GMP laboratory at Karolinska Institutet gives companies the opportunity to develop products, drugs and treatments. It is hoped for an increased interest from the industry to cooperate. Professor Matti Sällberg, head of the pre GMP unit, talks more about how this can be helpful early in the development.

“We want to increase the interest from the industry to collaborate with researchers”2022-02-23T09:44:46+01:00
Go to Top